Retrogenix's unique cell microarray technology provides a fast, accurate and effective solution for discovering the human cell surface targets of antibodies, proteins, viruses and small molecules. This allows our global pharmaceutical clients to:- Overcome the critical deconvolution step in phenotypic drug discovery,- Uncover novel, high quality and exploitable drug targets, and- Explore off-target liabilities of lead candidatesFor more information please visit us at retrogenix.comTags: target deconvolution, cell microarray technology and drug discovery
Retrogenix is an England-based contract research organization that provides cancer immunology research and consulting services for the pharmaceutical industry.